• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Omalizumab alleviates pruritus in myeloproliferative neoplasms.

作者信息

Ravn Landtblom Anna, Ungerstedt Johanna, Hedlund Anette, Tobiasson Magnus, Deneberg Stefan, Jädersten Martin

机构信息

Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden; Department of Hematology, Karolinska University Hospital, Stockholm.

Department of Hematology, Karolinska University Hospital, Stockholm, Sweden; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm.

出版信息

Haematologica. 2023 Jul 1;108(7):1968-1971. doi: 10.3324/haematol.2022.281639.

DOI:10.3324/haematol.2022.281639
PMID:36700402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10316269/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe7/10316269/ada8e306195b/1081968.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe7/10316269/ada8e306195b/1081968.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe7/10316269/ada8e306195b/1081968.fig1.jpg

相似文献

1
Omalizumab alleviates pruritus in myeloproliferative neoplasms.奥马珠单抗可减轻骨髓增殖性肿瘤中的瘙痒症状。
Haematologica. 2023 Jul 1;108(7):1968-1971. doi: 10.3324/haematol.2022.281639.
2
Danazol in refractory pruritus of myeloproliferative disorders.达那唑治疗骨髓增殖性疾病难治性瘙痒症。
Am J Hematol. 1997 Feb;54(2):172-3. doi: 10.1002/(sici)1096-8652(199702)54:2<172::aid-ajh16>3.0.co;2-h.
3
[Itching of the skin in myeloproliferative disease treated with cimetidine].[用西咪替丁治疗骨髓增殖性疾病时的皮肤瘙痒]
Ugeskr Laeger. 1985 Apr 22;147(17):1403-4.
4
Cholinergic pruritus responding to omalizumab.
Clin Exp Dermatol. 2020 Mar;45(2):264-266. doi: 10.1111/ced.14052. Epub 2019 Sep 10.
5
Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者水致瘙痒的临床特征
Br J Dermatol. 2017 Jan;176(1):255-258. doi: 10.1111/bjd.14809. Epub 2016 Dec 22.
6
Omalizumab for the management of refractory aquagenic pruritus.奥马珠单抗用于难治性水源性瘙痒的治疗
J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1316-e1317. doi: 10.1111/jdv.19306. Epub 2023 Jul 11.
7
Reply to 'Omalizumab for the management of refractory aquagenic pruritus'.对“奥马珠单抗治疗难治性水源性瘙痒”的回复
J Eur Acad Dermatol Venereol. 2024 May;38(5):e380-e381. doi: 10.1111/jdv.19602. Epub 2023 Nov 10.
8
Cutaneous manifestations of JAK2+ myeloproliferative neoplasms.JAK2 阳性骨髓增殖性肿瘤的皮肤表现
Clin Exp Dermatol. 2018 Jul;43(5):615-616. doi: 10.1111/ced.13562. Epub 2018 May 13.
9
Cimetidine for the treatment of pruritus.西咪替丁用于治疗瘙痒症。
N Engl J Med. 1979 Feb 15;300(7):370. doi: 10.1056/nejm197902153000721.
10
Aquagenic pruritus successfully treated with omalizumab.
Clin Exp Dermatol. 2018 Oct;43(7):858-859. doi: 10.1111/ced.13415. Epub 2018 Feb 16.

本文引用的文献

1
Clinical impact of omalizumab in refractory chronic urticaria: One centre experience.奥马珠单抗治疗难治性慢性荨麻疹的临床疗效：单中心经验
Exp Ther Med. 2019 Dec;18(6):5078-5081. doi: 10.3892/etm.2019.8126. Epub 2019 Oct 24.
2
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.奥马珠单抗，第一种可用于重度哮喘生物治疗的抗体：超过十年的真实世界疗效。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618810192. doi: 10.1177/1753466618810192.
3
Aquagenic pruritus successfully treated with omalizumab.
Clin Exp Dermatol. 2018 Oct;43(7):858-859. doi: 10.1111/ced.13415. Epub 2018 Feb 16.
4
Aquagenic Pruritus in Polycythemia Vera: Clinical Characteristics.真性红细胞增多症所致水致瘙痒症：临床特征。
Acta Derm Venereol. 2018 Apr 27;98(5):496-500. doi: 10.2340/00015555-2906.
5
Burden of Aquagenic Pruritus in Polycythaemia Vera.真性红细胞增多症所致水致瘙痒症的负担。
Acta Derm Venereol. 2018 Feb 7;98(2):185-190. doi: 10.2340/00015555-2812.
6
Clinical characteristics of aquagenic pruritus in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者水致瘙痒的临床特征
Br J Dermatol. 2017 Jan;176(1):255-258. doi: 10.1111/bjd.14809. Epub 2016 Dec 22.
7
Off-Label Uses of Omalizumab.奥马珠单抗的非标签用途。
Clin Rev Allergy Immunol. 2016 Feb;50(1):84-96. doi: 10.1007/s12016-015-8490-y.
8
Ruxolitinib versus standard therapy for the treatment of polycythemia vera.芦可替尼与标准疗法治疗真性红细胞增多症的对比
N Engl J Med. 2015 Jan 29;372(5):426-35. doi: 10.1056/NEJMoa1409002.
9
Aquagenic pruritus in polycythemia vera: characteristics and influence on quality of life in 441 patients.真性红细胞增多症中的水诱发瘙痒症：441 例患者的特征及其对生活质量的影响。
Am J Hematol. 2013 Aug;88(8):665-9. doi: 10.1002/ajh.23474. Epub 2013 Jul 8.
10
Polycythemia vera-associated pruritus and its management.真性红细胞增多症相关性瘙痒及其管理。
Eur J Clin Invest. 2010 Sep;40(9):828-34. doi: 10.1111/j.1365-2362.2010.02334.x. Epub 2010 Jul 1.